Report sees opportunity in coprocessed excipients

April 14, 2016

A new report from BCC Research analyzes this market and says that co-processed excipients represent a significant opportunity for producers.

Growing demand for pharmaceuticals and biopharmaceuticals is set to increase demand for excipients — natural or synthetic ingredients used along with the active ingredient in a drug formulation.

A new report from BCC Research analyzes this market and says that coprocessed excipients represent a significant opportunity for producers.

With new drug molecules being developed, including both small molecule and biologic drugs, pharmaceutical manufacturers need new excipients to increase options for the formulation and delivery. However, high development costs and stringent regulatory requirements mean that few new excipients have reached the market in recent years.

Taking a different approach, some producers are focusing on coprocessing existing approved excipients. According to the report, innovative coprocessed excipients, or excipient composites, are being engineered to achieve the properties of key components of the tableting blend in a single, highly flowable and compressible granular material.

“With the increasing development of new chemical entities, there is a huge opportunity for the development of coprocessed excipients, and development of such innovative coprocessed excipients with multi-functionality is beneficial for the market,” said BCC Research analyst Shalini S. Dewan. “Yet coprocessed excipients have yet to find their way into official monographs, which is one of the major obstacles to their success in the marketplace.”

BCC Research expects the global excipients market to reach almost $6.9 billion by 2020 from approximately $6.3 billion in 2015, reflecting a five-year compound annual growth rate (CAGR) of 1.9 percent. Organic excipients account for most of the market and are projected to reach $6.3 billion by 2020, growing at an annual rate of 1.7 percent from nearly $5.8 billion in 2015. The inorganic excipients market is projected to grow by 4.3 percent, from $351.9 million in 2015 to $433.7 million in 2020.

Sponsored Recommendations

Choosing The Right Partner for CHIPS Act Investments

As the U.S. looks to invest in the semiconductor research and production using CHIPS Act 2022 funding, it's important to choose the right partner.

EMWD Uses Technology to Meet Sustainability Goals

Eastern Municipal Water District pilots artificial intelligence-enabled control and machine learning to help save energy, reduce costs, and improve quality.

Protein Processing Solutions: Automation & Control

For protein processors looking to address industry challenges, improve efficiency, and stay ahead in a competitive market, Rockwell Automation offers tailored automation, control...

Automotive Manufacturing Innovation: Smart Solutions for a Connected Future

Rockwell Automation provides automation and control systems tailored for the automotive and tire industries, supporting electric vehicle production, tire production, battery production...